DE69727268D1 - Substanz fa-70d, herstellungsverfahren und verwendungen - Google Patents

Substanz fa-70d, herstellungsverfahren und verwendungen

Info

Publication number
DE69727268D1
DE69727268D1 DE69727268T DE69727268T DE69727268D1 DE 69727268 D1 DE69727268 D1 DE 69727268D1 DE 69727268 T DE69727268 T DE 69727268T DE 69727268 T DE69727268 T DE 69727268T DE 69727268 D1 DE69727268 D1 DE 69727268D1
Authority
DE
Germany
Prior art keywords
compound
substance
drug
manufacturing
osteoporosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69727268T
Other languages
English (en)
Other versions
DE69727268T2 (de
Inventor
Shizuo Kitano
Toru Sasaki
Kenichiro Yoshida
Toshio Otani
Lei Yu
Yun Wu
Nobuhiko Katsunuma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69727268D1 publication Critical patent/DE69727268D1/de
Publication of DE69727268T2 publication Critical patent/DE69727268T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69727268T 1996-02-21 1997-02-20 Substanz fa-70d, herstellungsverfahren und verwendungen Expired - Fee Related DE69727268T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3352396 1996-02-21
JP3352396 1996-02-21
PCT/JP1997/000472 WO1997031122A1 (fr) 1996-02-21 1997-02-20 Substance fa-70d, procede de fabrication et utilisations

Publications (2)

Publication Number Publication Date
DE69727268D1 true DE69727268D1 (de) 2004-02-26
DE69727268T2 DE69727268T2 (de) 2004-12-16

Family

ID=12388910

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69727268T Expired - Fee Related DE69727268T2 (de) 1996-02-21 1997-02-20 Substanz fa-70d, herstellungsverfahren und verwendungen

Country Status (9)

Country Link
US (1) US5914348A (de)
EP (1) EP0822260B1 (de)
JP (1) JP3111240B2 (de)
KR (1) KR100271997B1 (de)
AT (1) ATE258229T1 (de)
AU (1) AU695190B2 (de)
CA (1) CA2217729C (de)
DE (1) DE69727268T2 (de)
WO (1) WO1997031122A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677360B2 (en) * 1998-12-16 2004-01-13 Bayer Aktiengesellschaft Biphenyl and biphenyl-analogous compounds as integrin antagonists
US6420396B1 (en) 1998-12-16 2002-07-16 Beiersdorf Ag Biphenyl and biphenyl-analogous compounds as integrin antagonists
KR20020042333A (ko) * 2000-11-30 2002-06-05 이계준 프로테아제 억제 활성을 갖는 약학적 조성물
EP1568377A1 (de) * 2002-11-29 2005-08-31 Morinaga Milk Industry Co., Ltd. Cysteinprotease-hemmer
CN100379448C (zh) * 2002-11-29 2008-04-09 森永乳业株式会社 蛋白酶抑制剂
CN115785200A (zh) * 2020-02-17 2023-03-14 中国医学科学院医药生物技术研究所 一组具有抗病毒活性的肽类化合物奥米克欣b族化合物的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU667995B2 (en) * 1993-02-15 1996-04-18 Bayer Aktiengesellschaft New pseudopeptides having an antiviral action
JPH07123995A (ja) * 1993-11-04 1995-05-16 Yamanouchi Pharmaceut Co Ltd トリペプチド化合物
JPH083188A (ja) * 1994-06-15 1996-01-09 Sankyo Co Ltd 新規化合物キモスタチノール類及びその製法
JPH08151394A (ja) * 1994-11-25 1996-06-11 Yamanouchi Pharmaceut Co Ltd ジペプチド化合物

Also Published As

Publication number Publication date
CA2217729C (en) 2001-04-10
ATE258229T1 (de) 2004-02-15
WO1997031122A1 (fr) 1997-08-28
JP3111240B2 (ja) 2000-11-20
CA2217729A1 (en) 1997-08-28
AU1734097A (en) 1997-09-10
DE69727268T2 (de) 2004-12-16
EP0822260B1 (de) 2004-01-21
KR100271997B1 (ko) 2000-11-15
US5914348A (en) 1999-06-22
EP0822260A4 (de) 2000-05-31
EP0822260A1 (de) 1998-02-04
KR19990007955A (ko) 1999-01-25
AU695190B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
FI925787A (fi) Proteolytiska enzymers sackarinderivatinhibitorer
NO941937D0 (no) Sakarinderivater som inhiberer proteolytiske enzymer
TR199800849T2 (xx) Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
NO950297L (no) Prolinamidderivater
NO912410L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater.
NO20014507L (no) Legemiddel for behandling av sukkersyke
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
DE69727268D1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
DK1123937T3 (da) Substans GM-95, fremgangsmåde til dets fremstilling samt anvendelse deraf
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
ATE252563T1 (de) Vorsorge-/heilmittel fur die komplikationen von diabetes
SE9700244D0 (sv) Novel antibacterial protein
IT1223395B (it) Composti ad attivita' cardiovascolare
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
ES2179668T3 (es) Un compuesto wf002, su produccion y su uso.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee